Advertisement
U.S. markets open in 3 hours 46 minutes
  • S&P Futures

    4,981.50
    -10.00 (-0.20%)
     
  • Dow Futures

    38,582.00
    -60.00 (-0.16%)
     
  • Nasdaq Futures

    17,538.00
    -69.25 (-0.39%)
     
  • Russell 2000 Futures

    2,004.00
    -6.20 (-0.31%)
     
  • Crude Oil

    76.56
    -0.48 (-0.62%)
     
  • Gold

    2,039.60
    -0.20 (-0.01%)
     
  • Silver

    23.15
    +0.01 (+0.06%)
     
  • EUR/USD

    1.0803
    -0.0009 (-0.09%)
     
  • 10-Yr Bond

    4.2750
    0.0000 (0.00%)
     
  • Vix

    15.60
    +0.18 (+1.17%)
     
  • GBP/USD

    1.2619
    -0.0007 (-0.05%)
     
  • USD/JPY

    150.0240
    +0.0980 (+0.07%)
     
  • Bitcoin USD

    51,230.49
    -819.79 (-1.57%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,658.22
    -60.99 (-0.79%)
     
  • Nikkei 225

    38,262.16
    -101.45 (-0.26%)
     

Trisura Group Reports Third Quarter 2023 Results

Trisura Group Ltd
Trisura Group Ltd

TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the third quarter of 2023.

David Clare, President and CEO of Trisura, stated, “Trisura reported strong performance in the quarter with Operating net income of $31.7 million, or $0.67 per share, achieved through measured growth, underwriting profitability and enhanced investment income. Quarterly Net income of $14.8 million, or $0.31 per share, was impacted by the run-off of a US program and unrealized losses in the investment portfolio, partially offset by one-time benefits in the primary lines business.

Maturation of our business and continued expansion with distribution partners drove increased market share and resulted in insurance revenue growth of 32.7%. In Canada, disciplined underwriting yielded a Combined ratio of 75.0%. US fronting demonstrated strong fundamentals, with an improvement in Operating net income.

Net investment income grew 105.0% in the quarter, reaching $13.5 million through higher risk-adjusted yields and an increased size of the investment portfolio.

Strong earnings and an equity raise in the quarter lifted book value to almost $600 million. Our business remains well-capitalized, supported by surplus capital, a $50 million revolving credit facility, an 11.1% debt-to-capital ratio and a conservatively positioned investment portfolio.”

Financial Highlights

  • Insurance revenue growth of 32.7% in Q3 2023 reflected sustained momentum across North America.

  • Net income of $14.8 million in the quarter decreased compared to prior period, primarily as a result of costs related to the run-off of a US fronting program. Operating net income(1) of $31.7 million in the quarter grew 50.2% compared to prior period, driven by profitable growth in Canada and growth in core operations(2) in the US, as well as growth in Net investment income.

  • EPS of $0.31 in Q3 2023 compared to $0.53 in Q3 2022. Operating EPS(3) of $0.67 for the quarter compared to $0.46 in the prior year.

  • Book value per share(4) of $12.58 increased 7.4% from September 30, 2022, driven by our August 2023 equity raise, strong Canadian earnings, but diluted by the write down on reinsurance recoverables, the associated run-off and unrealized losses on investments.

  • ROE(4) of 2.8% compared to 19.9% in Q3 2022, below our mid-teens target as a result of the write down on reinsurance recoverables and losses associated with the run-off program. Operating ROE(5) of 20.2% exceeded our target, demonstrating the strength of our core operations despite significant growth and a larger capital base.

Amounts in C$ millions

Q3 2023

Q3 2022

Variance

Q3 2023
YTD

Q3 2022
YTD

Variance

Insurance revenue

730.7

 

550.9

 

32.7%

 

2,034.2

 

1,419.2

 

43.3%

 

Net income

14.8

 

24.2

 

(38.7%)

 

55.6

 

68.5

 

(18.8%)

 

Operating net income(1)

31.7

 

21.1

 

50.2%

 

84.3

 

59.7

 

41.2%

 

EPS – diluted, $

0.31

 

0.53

 

(41.5%)

 

1.18

 

1.58

 

(25.3%)

 

Operating EPS – diluted, $(3)

0.67

 

0.46

 

45.7%

 

1.80

 

1.38

 

30.4%

 

Book value per share, $(4)

12.58

 

11.71

 

7.4%

 

12.58

 

11.71

 

7.4%

 

Debt-to-Capital ratio(4)(11)

11.1%

 

12.5%

 

(1.4pts)

 

11.1%

 

12.5%

 

(1.4pts)

 

ROE(4)

2.8%

 

19.9%

 

(17.1pts)

 

2.8%

 

19.9%

 

(17.1pts)

 

Operating ROE(5)

20.2%

 

19.2%

 

1.0pts

 

20.2%

 

19.2%

 

1.0pts

 

Combined ratio – Canada

75.0%

 

81.8%

 

(6.8pts)

 

79.3%

 

79.8%

 

(0.5pts)

 

Fronting operational ratio – US(4)

117.2%

 

83.9%

 

33.3pts

 

101.0%

 

79.3%

 

21.7pts

 

Fronting operational ratio excluding run-off – US(6)

85.5%

 

83.9%

 

1.6pts

 

83.9%

 

79.3%

 

4.6pts

 


Insurance Operations

  • Insurance revenue in Canada of $221.1 million in the quarter increased by 30.2% compared to Q3 2022, reflecting increased market share, expansion of distribution relationships, new fronting arrangements and the benefit of stable market pricing conditions in certain lines of business. Strong underwriting performance across all lines contributed to a Combined ratio of 75.0%, a ROE of 28.8% and Operating ROE of 29.7% in Q3 2023.

  • Insurance revenue in the US of $509.6 million in the quarter increased by 33.7%, compared to Q3 2022, reflecting favourable market conditions and maturation of existing programs. Fee income(7) of $20.8 million in the quarter increased by 14.1% compared to Q3 2022. Net loss of $6.5 million was the result of costs related to the run-off. Operating net income of $11.4 million in the quarter grew 51.9% compared to Q3 2022 and supported a 15.2% Operating ROE.

Capital

  • In August 2023, the Company raised $51.2 million in equity capital to support growth across the platform.

  • The Minimum Capital Test ratio(8) of our regulated Canadian subsidiary was 246% as at September 30, 2023 (233% as at December 31, 2022), which comfortably exceeded regulatory requirements(9) of 150%.

  • As at December 31, 2022, the Risk-Based Capital of the regulated insurance companies of Trisura US were in excess of the various company action levels of the states in which they are licensed.

  • Consolidated debt-to-capital ratio of 11.1% as at September 30, 2023 is below our long-term target of 20.0%.

  • The company holds surplus capital and has a $50 million revolving credit facility. In July 2023, $10 million USD was utilized from the revolving credit facility for purposes of issuing a letter of credit, in relation to our US Surety operations.

Investments

  • Net investment income rose 105.0% in the quarter compared to Q3 2022. The portfolio benefited from higher risk-adjusted yields, increased capital generated from strong operational performance and the July 2022 and August 2023 equity raises.

Earnings Conference Call

Trisura will host its Third Quarter Earnings Conference Call to review financial results at 9:00 a.m. ET on Friday, November 3rd, 2023.

To listen to the call via live audio webcast, please follow the link below:

https://edge.media-server.com/mmc/p/bckpvkwt

A replay of the call will be available through the link above.

About Trisura Group

Trisura Group Ltd. is a specialty insurance provider operating in the Surety, Risk Solutions, Corporate Insurance, and Fronting business lines of the market. Trisura has investments in wholly owned subsidiaries through which it conducts insurance and reinsurance operations. Those operations are primarily in Canada (“Trisura Canada”) and the United States (“Trisura US”). Trisura Group Ltd. Is listed on the Toronto Stock Exchange under the symbol “TSU”.

Further information is available at http://www.trisura.com. Important information may be disseminated exclusively via the website; investors should consult the site to access this information. Details regarding the operations of Trisura Group Ltd. Are also set forth in regulatory filings. A copy of the filings may be obtained on Trisura Group’s SEDAR profile at www.sedar.com.

For more information, please contact:

Name: Bryan Sinclair
Tel: 416 607 2135
Email: bryan.sinclair@trisura.com


Trisura Group Ltd.

Condensed Interim Consolidated Statements of Financial Position

As at September 30, 2023 and December 31, 2022

(in thousands of Canadian dollars, except as otherwise noted)

 

As at

September 30, 2023

December 31, 2022

Cash and cash equivalents

531,484

406,368

Investments

842,260

765,375

Other assets

34,865

61,852

Reinsurance contract assets

1,948,477

1,527,799

Capital assets and intangible assets

17,154

19,529

Deferred tax assets

30,669

17,942

Total assets

3,404,909

2,798,865

Insurance contract liabilities

2,617,452

2,165,103

Other liabilities

113,771

65,111

Loan payable

75,000

75,000

Total liabilities

2,806,223

2,305,214

Shareholders' equity

598,686

493,651

Total liabilities and shareholders' equity

3,404,909

2,798,865


Trisura Group Ltd.

Condensed Interim Consolidated Statements of Comprehensive Income

For the three and nine months ended September 30

(in thousands of Canadian dollars, except as otherwise noted)

 

 

Q3 2023

Q3 2022

Q3 2023 YTD

Q3 2022 YTD

Insurance revenue

730,714

 

550,861

 

2,034,234

 

1,419,173

 

Insurance service expenses

(562,419)

 

(547,859)

 

(1,630,079)

 

(1,268,481)

 

Net (expense) income from reinsurance contracts assets

(143,546)

 

25,588

 

(322,979)

 

(67,744)

 

Insurance service result

24,749

 

28,590

 

81,176

 

82,948

 

Net investment income

13,493

 

6,583

 

35,463

 

15,683

 

Net (losses) gains

(8,708)

 

3,723

 

(17,790)

 

4,690

 

Net credit impairment losses

(258)

 

-

 

(31)

 

-

 

Total investment income

4,527

 

10,306

 

17,642

 

20,373

 

Finance (expenses) income from insurance contracts

(11,521)

 

(622)

 

(48,159)

 

11,982

 

Finance income (expenses) from reinsurance contracts

10,623

 

903

 

42,248

 

(9,765)

 

Net insurance finance (expenses) income

(898)

 

281

 

(5,911)

 

2,217

 

Net financial result

3,629

 

10,587

 

11,731

 

22,590

 

Net insurance and financial result

28,378

 

39,177

 

92,907

 

105,538

 

Other income

847

 

663

 

6,927

 

5,860

 

Other operating expenses

(7,094)

 

(8,097)

 

(22,601)

 

(19,429)

 

Other finance costs

(643)

 

(823)

 

(1,844)

 

(2,056)

 

Income before income taxes

21,488

 

30,920

 

75,389

 

89,913

 

Income tax expense

(6,650)

 

(6,696)

 

(19,768)

 

(21,408)

 

Net income

14,838

 

24,224

 

55,621

 

68,505

 

Operating net income

31,725

 

21,116

 

84,327

 

59,730

 

Other comprehensive income (loss)

1,826

 

(297)

 

(2,124)

 

(43,754)

 

Comprehensive income

16,664

 

23,927

 

53,497

 

24,751

 


Trisura Group Ltd.

Condensed Interim Consolidated Statements of Cash Flows

For the three and nine months ended September 30

(in thousands of Canadian dollars, except as otherwise noted)

 

 

Q3 2023

Q3 2022

Q3 2023 YTD

Q3 2022 YTD

Net income

14,838

 

24,224

 

55,621

 

68,505

 

Non-cash items

8,758

 

(5,035)

 

16,991

 

1,232

 

Change in working capital

130,075

 

17,995

 

93,736

 

69,569

 

Realized losses (gains)

1,740

 

(1,625)

 

2,181

 

(6,979)

 

Income taxes paid

(432)

 

(7,305)

 

(8,105)

 

(28,829)

 

Interest paid

(85)

 

(110)

 

(1,324)

 

(1,606)

 

Net cash from operating activities

154,894

 

28,144

 

159,100

 

101,892

 

Proceeds on disposal of investments

36,619

 

22,227

 

89,598

 

120,083

 

Purchases of investments

(52,352)

 

(156,651)

 

(178,120)

 

(333,318)

 

Net purchases of capital and intangible assets

(339)

 

(1,327)

 

(746)

 

(1,734)

 

Net cash used in investing activities

(16,072)

 

(135,751)

 

(89,268)

 

(214,969)

 

Shares issued

50,859

 

143,494

 

51,570

 

145,160

 

Shares purchased under Restricted Share Units plan

(175)

 

(61)

 

(1,845)

 

(2,167)

 

Loans received

-

 

-

 

-

 

30,000

 

Loans repaid

-

 

(30,000)

 

-

 

(30,000)

 

Lease payments

(502)

 

(477)

 

(1,524)

 

(1,424)

 

Net cash from financing activities

50,182

 

112,956

 

48,201

 

141,569

 

Net increase in cash and cash equivalents,
and short-term securities, during the period

189,004

 

5,349

 

118,033

 

28,492

 

Cash and cash equivalents, beginning of period

340,825

 

367,966

 

406,368

 

341,319

 

Currency translation

1,655

 

11,238

 

7,083

 

14,742

 

Cash and cash equivalents, and short-term securities, end of period

531,484

 

384,553

 

531,484

 

384,553

 


Non-IFRS Financial Measures

Table 1 – Reconciliation of reported Net income to Operating net income(4): reflect Net income, adjusted for certain items to normalize earnings to core operations in order to reflect our North American specialty operations.

 

Q3 2023

Q3 2022

2023

 

2022

 

Net income

14,838

 

24,224

 

55,621

 

68,505

 

Adjustments:

 

 

 

 

Non-recurring items

15,375

 

-

 

23,437

 

-

 

Impact of share based compensation

(1,948)

 

441

 

(3,503)

 

(2,507)

 

Impact of movement in yield curve within Finance income from insurance and reinsurance contracts

(1,204)

 

(421)

 

(1,348)

 

(3,986)

 

Net losses (gains)

8,708

 

(3,723)

 

17,790

 

(4,690)

 

Net credit impairment losses

258

 

-

 

31

 

-

 

Tax impact of above items

(4,302)

 

595

 

(7,701)

 

2,408

 

Operating net income

31,725

 

21,116

 

84,327

 

59,730

 


Table 2 – ROE
(4) and Operating ROE(5): a measure of the Company’s use of equity.

 

Q3 2023

Q3 2022

LTM net income

14,911

 

75,286

 

LTM average equity

526,049

 

377,778

 

ROE

2.8%

 

19.9%

 

Operating LTM net income(5)

106,253

 

72,489

 

LTM average equity

526,049

 

377,778

 

Operating LTM ROE

20.2%

 

19.2%

 


Table 3 – Reconciliation of Average equity
(10) to LTM average equity: LTM average equity is used in calculating Operating ROE.

 

 

Q3 2023

Q3 2022

Average equity

567,857

 

438,032

 

Adjustments: days in quarter proration

(41,808)

 

(60,254)

 

LTM average equity

526,049

 

377,778

 


Footnotes

(1) See section on Non-IFRS financial measures table 10.2.1 in Q3 2023 MD&A for details on composition. Operating net income is a non-IFRS financial measure. Non-IFRS financial measures are not standardized financial measures under the financial reporting framework used to prepare the financial statements of the Company to which the measure relates and might not be comparable to similar financial measures disclosed by other companies. Details and an explanation of how it provides useful information to an investor can be found in table 1.

(2) See Section 10, Operating Metrics in Q3 2023 MD&A for the definition of Operating Net Income, and for further explanation of “core operations”.

(3) This is a non-IFRS ratio, see table 10.2 in Q3 2023 MD&A for details on composition, as well as each non-IFRS financial measure used as a component of the ratio, and an explanation of how it provides useful information to an investor. Non-IFRS ratios are not standardized under the financial reporting framework used to prepare the financial statements of the Company to which the ratio relates and might not be comparable to similar ratios disclosed by other companies. To access MD&A, see Trisura’s website or SEDAR at www.sedar.com.

(4) This is a supplementary financial measure. Refer to Q3 2023 MD&A, Section 10, Operating Metrics table for its composition.

(5) This is a non-IFRS ratio. See table 10.4 in Q3 2023 MD&A for details on composition, as well as each non-IFRS financial measure used as a component of ratio, and an explanation of how it provides useful information to an investor.

(6) This is a non-IFRS financial measure. Adjusted figures exclude the impacts from write down of reinsurance recoverables, and the run-off program.

(7) This is a non-IFRS financial measure. See table 10.5.5 in Q3 2023 MDA for details on composition.

(8) This measure is calculated in accordance with the Office of the Superintendent of Financial Institutions Canada’s (OSFI’s) Guideline A, Minimum Capital Test.

(9) This target is in accordance with OSFI’s Guideline A-4, Regulatory Capital and Internal Capital Targets.

(10) Average equity is calculated as the sum of opening equity and closing equity over the last twelve months, divided by two.

(11) The Q3 2022 and Q3 2022 YTD metric has not been restated to reflect the adoption of IFRS 9 and IFRS 17.

Cautionary Statement Regarding Forward-Looking Statements and Information

Note: This news release contains “forward-looking information” within the meaning of Canadian provincial securities laws and “forward-looking statements” within the meaning of applicable Canadian securities regulations. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, include statements regarding operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, strategies and outlook of the Company and its subsidiaries, as well as the outlook for North American and international economies for the current fiscal year and subsequent periods, and include words such as “expects,” “likely,” “anticipates,” “plans,” “believes,” “estimates,” “seeks,” “intends,” “targets,” “projects,” “forecasts” or negative versions thereof and other similar expressions, or future or conditional verbs such as “may,” “will,” “should,” “would” and “could”.

Although we believe that our anticipated future results, performance or achievements expressed or implied by the forward-looking statements and information are based upon reasonable assumptions and expectations, the reader should not place undue reliance on forward-looking statements and information because they involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, which may cause the actual results, performance or achievements of our Company to differ materially from anticipated future results, performance or achievement expressed or implied by such forward-looking statements and information.

Factors that could cause actual results to differ materially from those contemplated or implied by forward-looking statements include, but are not limited to: the impact or unanticipated impact of general economic, political and market factors in the countries in which we do business; the behaviour of financial markets, including fluctuations in interest and foreign exchange rates; global equity and capital markets and the availability of equity and debt financing and refinancing within these markets; insurance risks including pricing risk, concentration risk and exposure to large losses, and risks associated with estimates of loss reserves; strategic actions including dispositions; the ability to complete and effectively integrate acquisitions into existing operations and the ability to attain expected benefits; changes in accounting policies and methods used to report financial condition (including uncertainties associated with critical accounting assumptions and estimates); the ability to appropriately manage human capital; the effect of applying future accounting changes; business competition; operational and reputational risks; technological change; changes in government regulation and legislation within the countries in which we operate; governmental investigations; litigation; changes in tax laws; changes in capital requirements; changes in reinsurance arrangements and availability and cost of reinsurance; ability to collect amounts owed; catastrophic events, such as earthquakes, hurricanes or pandemics; developments related to COVID-19, including the impact of COVID-19 on the economy and global financial markets; the possible impact of international conflicts and other developments including terrorist acts and cyberterrorism; risks associated with reliance on distribution partners, capacity providers and program administrators; third party risks; risk that models used to manage the business do not function as expected; climate change risk; risk of economic downturn; risk of inflation and other risks and factors detailed from time to time in our documents filed with securities regulators in Canada.

We caution that the foregoing list of important factors that may affect future results is not exhaustive. When relying on our forward-looking statements, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statements or information, whether written or oral, that may be as a result of new information, future events or otherwise.

Cautionary Non-IFRS and Other Financial Measures

Reported results conform to generally accepted accounting principles (GAAP), in accordance with IFRS. In addition to reported results, the Company also presents certain financial measures, including non-IFRS financial measures that are historical, non-IFRS ratios, and supplementary financial measures, to assess results. Non-IFRS financial measures, such as operating net income, are utilized to assess the Company’s overall performance. To arrive at operating results, the Company adjusts for certain items to normalize earnings to core operations, in order to reflect our North American specialty operations. Non-IFRS ratios include a non-IFRS financial measure as one or more of its components. Examples of non-IFRS ratios include operating diluted earnings per share and operating ROE. The Company believes that non-IFRS financial measures and non-IFRS ratios provide the reader with an enhanced understanding of our results and related trends and increase transparency and clarity into the core results of the business. Non-IFRS financial measures and non-IFRS ratios are not standardized terms under IFRS and, therefore, may not be comparable to similar terms used by other companies. Supplementary financial measures depict the Company’s financial performance and position, and are explained in this document where they first appear, and incorporates information by reference to the Company’s current MD&A, for the three and nine months ended September 30, 2023. To access MD&A, see Trisura’s website or SEDAR at www.sedar.com. These measures are pursuant to National Instrument 52-112 Non-GAAP and Other Financial Measures Disclosure.


Advertisement